Table of Content

1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 28
TABLE 1 INCLUSIONS & EXCLUSIONS 28
1.3 MARKET SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY 30
1.5 LIMITATIONS 30
1.6 STAKEHOLDERS 30
1.7 SUMMARY OF CHANGES 31

2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 1 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 35
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 36
2.1.2.1 Breakdown of primaries 37
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37
2.2 MARKET ESTIMATION METHODOLOGY 37
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 38
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION 38
FIGURE 4 MARKET SIZE ESTIMATION: VENDOR REVENUE-BASED MARKET ESTIMATION 39
2.2.2 END USER-BASED MARKET ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: END USER-BASED MARKET ESTIMATION 40
2.2.3 PRIMARY RESEARCH VALIDATION 40
2.3 DATA TRIANGULATION METHODOLOGY 40
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 41
FIGURE 6 DATA TRIANGULATION METHODOLOGY 41
2.5 RESEARCH ASSUMPTIONS 42
2.6 RESEARCH LIMITATIONS 42

3 EXECUTIVE SUMMARY 43
FIGURE 7 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 43
FIGURE 8 ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2020 VS. 2025 (USD MILLION) 44
FIGURE 9 ELECTROPHYSIOLOGY MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 45
FIGURE 10 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD (2020-2025) 46

4 PREMIUM INSIGHTS 47
4.1 ELECTROPHYSIOLOGY MARKET OVERVIEW 47
FIGURE 11 TECHNOLOGICAL ADVANCEMENTS – KEY FACTORS DRIVING GROWTH OF GLOBAL ELECTROPHYSIOLOGY MARKET 47
4.2 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY INDICATION AND REGION 48
FIGURE 12 ATRIAL FIBRILLATION SEGMENT DOMINATED THE ASIA PACIFIC ELECTROPHYSIOLOGY MARKET IN 2019 48
4.3 GEOGRAPHIC ANALYSIS: ELECTROPHYSIOLOGY MARKET, BY PRODUCT AND REGION 49
FIGURE 13 ELECTROPHYSIOLOGY LABORATORY DEVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2019 49
4.4 ELECTROPHYSIOLOGY MARKET SHARE, BY END USER, 2020 VS. 2025 50
FIGURE 14 HOSPITALS & CARDIAC CENTERS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 50
4.5 GEOGRAPHICAL SNAPSHOT OF THE ELECTROPHYSIOLOGY MARKET 50
FIGURE 15 CHINA MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD (2020-2025) 50

5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
FIGURE 16 EVOLUTION OF ELECTROPHYSIOLOGY 51
5.2 MARKET DYNAMICS 52
FIGURE 17 ELECTROPHYSIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
5.2.1 DRIVERS 52
5.2.1.1 Technological advancements 52
5.2.1.1.1 Non-invasive cardiac mapping 52
5.2.1.1.2 Improved ablation 53
5.2.1.1.3 MRI guided ablation procedures 53
5.2.1.1.4 Ultrasound guidance in the EP Lab 54
5.2.1.2 New entrants in the market 54
TABLE 2 NEW ENTRANTS IN THE CARDIAC MAPPING SYSTEMS MARKET 54
5.2.1.3 Growing investments, funds, and grants 55
5.2.1.4 Increasing incidence of target diseases and procedures 56
5.2.2 RESTRAINTS 57
5.2.2.1 High cost of electrophysiology products and inadequate reimbursement 57
5.2.2.2 Unfavorable healthcare reforms in the US 57
5.2.2.3 Cost-intensive requirement for clinical data for new product launches along with availability of alternative technologies 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Emerging markets 58
_
5.2.4 CHALLENGES 59
5.2.4.1 Reuse and reprocessing of devices 59
5.2.4.2 Lack of skilled and experienced electrophysiologists 59
5.3 VALUE CHAIN ANALYSIS 60
FIGURE 18 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 60
5.4 REGULATORY ANALYSIS 61
5.4.1 NORTH AMERICA 61
5.4.1.1 US 61
TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION 61
TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 62
5.4.1.2 Canada 62
TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 62
FIGURE 19 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 63
5.4.2 EUROPE 64
FIGURE 20 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 65
5.4.3 ASIA PACIFIC 66
5.4.3.1 Japan 66
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 66
5.4.3.2 China 67
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES 67
5.4.3.3 India 68
5.5 COVID-19 IMPACT ON THE ELECTROPHYSIOLOGY MARKET 68

6 ELECTROPHYSIOLOGY MARKET, BY PRODUCT 71
6.1 INTRODUCTION 72
TABLE 8 ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 72
6.2 ELECTROPHYSIOLOGY LABORATORY DEVICES 72
TABLE 9 EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 73
TABLE 10 EP LABORATORY DEVICES MARKET, BY INDICATION,
2018–2025 (USD MILLION) 73
TABLE 11 EP LABORATORY DEVICES MARKET, BY END USER,
2018–2025 (USD MILLION) 73
TABLE 12 EP LABORATORY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 74
6.2.1 3D MAPPING SYSTEMS 74
6.2.1.1 Alternative technologies likely to hinder market growth 74
TABLE 13 3D MAPPING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION) 75
6.2.2 ELECTROPHYSIOLOGY RECORDING SYSTEMS 75
6.2.2.1 Increasing public-private funding to support market growth 75
TABLE 14 ELECTROPHYSIOLOGY RECORDING SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 76
6.2.3 RADIOFREQUENCY (RF) ABLATION SYSTEMS 76
6.2.3.1 Increased demand due to rising number of RF ablation procedures 76
TABLE 15 RF ABLATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION) 77
6.2.4 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) ULTRASOUNG IMAGING SYSTEMS 77
6.2.4.1 Advantages of ICE ultrasound imaging systems to support market growth 77
TABLE 16 ICE ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 78
6.2.5 ELECTROPHYSIOLOGY X-RAY SYSTEMS 78
6.2.5.1 Magnetic navigation systems to hamper market growth 78
TABLE 17 ELECTROPHYSIOLOGY X-RAY SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 78
6.2.6 OTHER ELECTROPHYSIOLOGY LABORATORY DEVICES 79
6.2.6.1 Favorable reimbursement likely to bolster growth of market 79
TABLE 18 OTHER ELECTROPHYSIOLOGY LABORATORY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 80
6.3 ELECTROPHYSIOLOGY ABLATION CATHETERS 80
TABLE 19 EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 80
TABLE 20 EP ABLATION CATHETERS MARKET, BY INDICATION,
2018–2025 (USD MILLION) 81
TABLE 21 EP ABLATION CATHETERS MARKET, BY END USER,
2018–2025 (USD MILLION) 81
TABLE 22 EP ABLATION CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION) 81
6.3.1 CRYOABLATION ELECTROPHYSIOLOGY CATHETERS 82
6.3.1.1 Significant therapeutic advantages to contribute to market growth 82
TABLE 23 CRYOABLATION EP CATHETERS MARKET, BY REGION,
2018–2025 (USD MILLION) 82
6.3.2 RADIOFREQUENCY (RF) ABLATION CATHETERS 83
6.3.2.1 Technological advancements to drive the market 83
TABLE 24 RF ABLATION CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION) 84
6.3.3 MICROWAVE ABLATION (MWA) SYSTEMS 84
6.3.3.1 Advantages over RF ablation catheters to support market growth 84
TABLE 25 MWA SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION) 85
6.3.4 LASER ABLATION SYSTEMS 85
6.3.4.1 Technologically advanced products to boost market growth 85
TABLE 26 LASER ABLATION SYSTEMS MARKET, BY REGION,
2018–2025 (USD MILLION) 86
6.4 ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 86
TABLE 27 EP DIAGNOSTIC CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 87
TABLE 28 EP DIAGNOSTIC CATHETERS MARKET, BY INDICATION,
2018–2025 (USD MILLION) 87
TABLE 29 EP DIAGNOSTIC CATHETERS MARKET, BY END USER,
2018–2025 (USD MILLION) 87
TABLE 30 EP DIAGNOSTIC CATHETERS MARKET, BY REGION,
2018–2025 (USD MILLION) 88
6.4.1 CONVENTIONAL ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 88
6.4.1.1 Increasing demand in emerging markets to support market growth 88
TABLE 31 CONVENTIONAL EP DIAGNOSTIC CATHETERS MARKET, BY REGION,
2018–2025 (USD MILLION) 89
6.4.2 ADVANCED ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 89
6.4.2.1 Advantages over conventional EP diagnostic catheters likely to drive market growth 89
TABLE 32 ADVANCED EP DIAGNOSTIC CATHETERS MARKET, BY REGION,
2018–2025 (USD MILLION) 89
6.4.3 ULTRASOUND ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS 90
6.4.3.1 Increased demand due to rising use of ICE ultrasound imaging systems 90
TABLE 33 ULTRASOUND EP DIAGNOSTIC CATHETERS MARKET, BY REGION,
2018–2025 (USD MILLION) 90
6.5 ACCESS DEVICES 91
6.5.1 LAUNCH OF TECHNOLOGICALLY ADVANCED PRODUCTS LIKELY TO SUPPORT MARKET GROWTH 91
TABLE 34 ACCESS DEVICES MARKET, BY INDICATION, 2018–2025 (USD MILLION) 91
TABLE 35 ACCESS DEVICES MARKET, BY END USER, 2018–2025 (USD MILLION) 91
TABLE 36 ACCESS DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION) 92
6.6 OTHER PRODUCTS 92
TABLE 37 OTHER PRODUCTS MARKET, BY INDICATION, 2018–2025 (USD MILLION) 92
TABLE 38 OTHER PRODUCTS MARKET, BY END USER, 2018–2025 (USD MILLION) 93
TABLE 39 OTHER PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION) 93

7 ELECTROPHYSIOLOGY MARKET, BY INDICATION 94
7.1 INTRODUCTION 95
TABLE 40 ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2018–2025 (USD MILLION) 95
7.2 ATRIAL FIBRILLATION 95
7.2.1 GROWING INITIATIVES TO SHOWCASE ADVANTAGES OF CATHETER ABLATION OVER ANTIARRHYTHMIC DRUGS TO DRIVE MARKET GROWTH 95
TABLE 41 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2018–2025 (USD MILLION) 96
7.3 ATRIAL FLUTTER 97
7.3.1 HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR TREATMENT OF ATRIAL FLUTTER CONTRIBUTING TO MARKET GROWTH 97
TABLE 42 ELECTROPHYSIOLOGY MARKET FOR ATRIAL FLUTTER, BY REGION,
2018–2025 (USD MILLION) 97
7.4 ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT) 98
7.4.1 INCREASING VALIDATION OF EFFICACY OF ELECTROPHYSIOLOGY DEVICES FOR AVNRT SUPPORTING SEGMENT GROWTH 98
TABLE 43 ELECTROPHYSIOLOGY MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY REGION, 2018–2025 (USD MILLION) 98
7.5 WOLFF-PARKINSON-WHITE SYNDROME (WPW) 98
7.5.1 PREFERENCE FOR RADIOFREQUENCY ABLATION OVER SURGERY TO TREAT WPW LIKELY TO SUPPORT MARKET GROWTH 98
TABLE 44 ELECTROPHYSIOLOGY MARKET FOR WOLFF-PARKINSON-WHITE SYNDROME, BY REGION, 2018–2025 (USD MILLION) 99
7.6 OTHER INDICATIONS 99
TABLE 45 ELECTROPHYSIOLOGY MARKET FOR OTHER INDICATIONS, BY REGION,
2018–2025 (USD MILLION) 100

8 ELECTROPHYSIOLOGY MARKET, BY END USER 101
8.1 INTRODUCTION 102
TABLE 46 ELECTROPHYSIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION) 102
8.2 HOSPITALS & CARDIAC CENTERS 102
8.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE THE END-USER MARKET 102
TABLE 47 ELECTROPHYSIOLOGY MARKET FOR HOSPITALS & CARDIAC CENTERS,
BY REGION, 2018–2025 (USD MILLION) 103
8.3 AMBULATORY SURGERY CENTERS 103
8.3.1 INCREASING NUMBER OF CENTERS IN THE US TO DRIVE ADOPTION OF ELECTROPHYSIOLOGY DEVICES 103
TABLE 48 ELECTROPHYSIOLOGY MARKET FOR AMBULATORY SURGERY CENTERS,
BY REGION, 2018–2025 (USD MILLION) 104

9 ELECTROPHYSIOLOGY MARKET, BY REGION 105
9.1 INTRODUCTION 106
TABLE 49 ELECTROPHYSIOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION) 106
9.2 NORTH AMERICA 107
FIGURE 21 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET SNAPSHOT 107
TABLE 50 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 108
TABLE 51 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 108
TABLE 52 NORTH AMERICA: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 108
TABLE 53 NORTH AMERICA: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 109
TABLE 54 NORTH AMERICA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 109
TABLE 55 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2018–2025 (USD MILLION) 109
TABLE 56 NORTH AMERICA: ELECTROPHYSIOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 110
9.2.1 US 110
9.2.1.1 Technological advancements driving market growth 110
TABLE 57 CLINICAL TRIALS RELATED TO ELECTROPHYSIOLOGY DEVICES 111
TABLE 58 US: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 111
TABLE 59 US: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 112
TABLE 60 US: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 112
TABLE 61 US: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
9.2.2 CANADA 113
9.2.2.1 Growing government funding for research to support market growth 113
TABLE 62 RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY 113
TABLE 63 CANADA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 114
TABLE 64 CANADA: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 115
TABLE 65 CANADA: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 115
TABLE 66 CANADA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 115
9.3 EUROPE 116
TABLE 67 EUROPE: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 116
TABLE 68 EUROPE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 117
TABLE 69 EUROPE: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 117
TABLE 70 EUROPE: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 117
TABLE 71 EUROPE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 118
TABLE 72 EUROPE: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2018–2025 (USD MILLION) 118
TABLE 73 EUROPE: ELECTROPHYSIOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 118
9.3.1 GERMANY 119
9.3.1.1 Rising healthcare expenditure and growing use of electrophysiology devices to drive market growth 119
TABLE 74 GERMANY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 119
TABLE 75 GERMANY: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
TABLE 76 GERMANY: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
TABLE 77 GERMANY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
9.3.2 UK 121
9.3.2.1 Growing geriatric population to support market growth 121
TABLE 78 UK: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 122
TABLE 79 UK: EP LABORATORY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 122
TABLE 80 UK: EP ABLATION CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 122
TABLE 81 UK: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
9.3.3 FRANCE 123
9.3.3.1 Increasing incidence of heart failure to support market growth 123
TABLE 82 FRANCE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 124
TABLE 83 FRANCE: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
TABLE 84 FRANCE: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 124
TABLE 85 FRANCE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
9.3.4 ITALY 125
9.3.4.1 Rising incidence of CVDs to drive the adoption of electrophysiology devices 125
TABLE 86 ITALY: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 125
TABLE 87 ITALY: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 88 ITALY: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 89 ITALY: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
9.3.5 SPAIN 127
9.3.5.1 Growing number of cardiac ablation procedures to drive market 127
TABLE 90 SPAIN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 127
TABLE 91 SPAIN: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 127
TABLE 92 SPAIN: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 93 SPAIN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
9.3.6 REST OF EUROPE (ROE) 128
TABLE 94 CARDIAC AF ABLATION PROCEDURES, BY COUNTRY, 2015 VS. 2016 129
TABLE 95 ROE: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 129
TABLE 96 ROE: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
TABLE 97 ROE: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
TABLE 98 ROE: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 130
9.4 ASIA PACIFIC 131
FIGURE 22 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET SNAPSHOT 132
TABLE 99 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 133
TABLE 100 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 133
TABLE 101 ASIA PACIFIC: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 102 ASIA PACIFIC: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 103 ASIA PACIFIC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 134
TABLE 104 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2018–2025 (USD MILLION) 135
TABLE 105 ASIA PACIFIC: ELECTROPHYSIOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 135
9.4.1 JAPAN 135
9.4.1.1 Favorable reimbursement scenario to support market growth 135
TABLE 106 JAPAN: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 136
TABLE 107 JAPAN: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 108 JAPAN: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 137
TABLE 109 JAPAN: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 137
9.4.2 CHINA 137
9.4.2.1 Growing geriatric population to drive the market 137
TABLE 110 CHINA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 138
TABLE 111 CHINA: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 138
TABLE 112 CHINA: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 139
TABLE 113 CHINA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 139
9.4.3 INDIA 139
9.4.3.1 Increasing healthcare initiatives by government supporting growth of market 139
TABLE 114 INDIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 140
TABLE 115 INDIA: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 140
TABLE 116 INDIA: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 141
TABLE 117 INDIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 141
9.4.4 AUSTRALIA 141
9.4.4.1 Increasing target disease burden to support market growth 141
TABLE 118 AUSTRALIA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 142
TABLE 119 AUSTRALIA: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 142
TABLE 120 AUSTRALIA: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 143
TABLE 121 AUSTRALIA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 143
9.4.5 SOUTH KOREA 143
9.4.5.1 Supportive government initiatives expected to positively impact market growth 143
TABLE 122 SOUTH KOREA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 144
TABLE 123 SOUTH KOREA: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 144
TABLE 124 SOUTH KOREA: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 145
TABLE 125 SOUTH KOREA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 145
9.4.6 REST OF ASIA PACIFIC 145
TABLE 126 ROAPAC: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 146
TABLE 127 ROAPAC: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 146
TABLE 128 ROAPAC: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 147
TABLE 129 ROAPAC: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 147
9.5 LATIN AMERICA 147
TABLE 130 LATAM: ELECTROPHYSIOLOGY MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 148
TABLE 131 LATAM: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 148
TABLE 132 LATAM: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 148
TABLE 133 LATAM: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 149
TABLE 134 LATAM: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 149
TABLE 135 LATAM: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2018–2025 (USD MILLION) 149
TABLE 136 LATAM: ELECTROPHYSIOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 150
9.5.1 BRAZIL 150
9.5.1.1 Key market owing to modernization of healthcare facilities 150
TABLE 137 BRAZIL: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 150
TABLE 138 BRAZIL: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 151
TABLE 139 BRAZIL: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 151
TABLE 140 BRAZIL: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 151
9.5.2 MEXICO 152
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth 152
TABLE 141 MEXICO: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 152
TABLE 142 MEXICO: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 153
TABLE 143 MEXICO: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 153
TABLE 144 MEXICO: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 153
9.5.3 REST OF LATIN AMERICA 154
TABLE 145 ROLA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 154
TABLE 146 ROLA: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 154
TABLE 147 ROLA: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 155
TABLE 148 ROLA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 155
9.6 MIDDLE EAST & AFRICA 155
TABLE 149 MEA: ELECTROPHYSIOLOGY MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 156
TABLE 150 MEA: EP LABORATORY DEVICES MARKET, BY TYPE,
2018–2025 (USD MILLION) 156
TABLE 151 MEA: EP ABLATION CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 157
TABLE 152 MEA: EP DIAGNOSTIC CATHETERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 157
TABLE 153 MEA: ELECTROPHYSIOLOGY MARKET, BY INDICATION,
2018–2025 (USD MILLION) 157
TABLE 154 MEA: ELECTROPHYSIOLOGY MARKET, BY END USER,
2018–2025 (USD MILLION) 158

10 COMPETITIVE LANDSCAPE 159
10.1 INTRODUCTION 159
FIGURE 23 KEY DEVELOPMENTS IN THE ELECTROPHYSIOLOGY MARKET, 2017–2019 159
10.2 MARKET SHARE ANALYSIS 159
FIGURE 24 ELECTROPHYSIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019 159
10.3 COMPETITIVE SCENARIO 160
10.3.1 PRODUCT LAUNCHES & APPROVALS 160
TABLE 155 PRODUCT LAUNCHES & APPROVALS (2017–2019) 160
10.3.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 161
TABLE 156 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017–2019) 161
10.3.3 ACQUISITIONS 162
TABLE 157 ACQUISITIONS (2017–2019) 162
_

11 COMPANY EVOLUTION MATRIX & COMPANY PROFILES 163
11.1 COMPETITIVE EVALUATION MATRIX AND METHODOLOGY 163
11.1.1 COMPETITVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS 163
11.1.2 VISIONARY LEADERS 163
11.1.3 INNOVATORS 163
11.1.4 EMERGING COMPANIES 164
11.1.5 DYNAMIC DIFFERENTIATORS 164
FIGURE 25 ELECTROPHYSIOLOGY MARKET COMPETITIVE LEADERSHIP MAPPING, 2019 164
11.2 COMPANY PROFILES 165
(Business Overview, Products Offered, Recent Developments, Competitive analysis)*
11.2.1 JOHNSON & JOHNSON 165
FIGURE 26 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019) 165
11.2.2 ABBOTT LABORATORIES 168
FIGURE 27 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 168
11.2.3 MEDTRONIC PLC 171
FIGURE 28 MEDTRONIC PLC: COMPANY SNAPSHOT (2019) 171
11.2.4 KONINKLIJKE PHILIPS N.V. 174
FIGURE 29 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019) 174
11.2.5 GE HEALTHCARE 176
FIGURE 30 GE HEALTHCARE: COMPANY SNAPSHOT (2019) 176
11.2.6 BOSTON SCIENTIFIC CORPORATION 178
FIGURE 31 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2019) 178
11.2.7 JAPAN LIFELINE 181
FIGURE 32 JAPAN LIFELINE: COMPANY SNAPSHOT (2019) 181
11.2.8 STEREOTAXIS 183
FIGURE 33 STEREOTAXIS: COMPANY SNAPSHOT (2019) 183
11.2.9 MICROPORT SCIENTIFIC CORPORATION 186
FIGURE 34 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019) 186
11.2.10 BIOTRONIK 189
11.2.11 ACUTUS MEDICAL 190
11.2.12 BAYLIS MEDICAL 192
11.2.13 EP SOLUTIONS SA 194
11.2.14 APN HEALTH, LLC 195
11.2.15 OSYPKA 196
11.2.16 EPMAP-SYSTEM 197
11.2.17 OTHER COMPANIES 198
11.2.17.1 CathRx Ltd 198
11.2.17.2 Merit Medical Systems 198
11.2.17.3 Cook Medical 199
11.2.17.4 CathVision 199
11.2.17.5 TZ Medical 200
11.2.17.6 Teleflex 200
11.2.17.7 Lepu Medical 201
11.2.17.8 Cardiofocus 201
11.2.17.9 Schwarzer Cardiotek 202
11.2.17.10 Imricor Medical Systems 202
*Business Overview, Products Offered, Recent Developments, Competitive analysis View might not be captured in case of unlisted companies.
12 APPENDIX 203
12.1 DISCUSSION GUIDE: ELECTROPHYSIOLOGY MARKET 203
12.3 AVAILABLE CUSTOMIZATIONS 209
12.4 RELATED REPORTS 209
12.5 AUTHOR DETAILS 211